BiotechTube
Home/Ridge Bio/Keith Loebner, PhD
KL

Keith Loebner, PhD

Director & Founding Investor

Ridge Bio

Therapeutic Areas

OncologyGenetic DiseasesUndisclosed Enzyme Deficiency Disorders

Ridge Bio Pipeline

DrugIndicationPhase
NativeLink Platform (e.g., NativeLink-AXC)Enabling Technology for Bioconjugates (ADCs, AOCs, Radiopharmaceuticals)Pre-clinical
ProTrigger PlatformEnabling Technology for Targeted Payload DeliveryPre-clinical
Catalytic MedicinesUndisclosed difficult drug targetsDiscovery/Pre-clinical

Leadership Team at Ridge Bio

WK
Weston Kightlinger, PhD
CEO and Co-founder
View full Ridge Bio profile